At FIRST MOUNTAIN MEDICAL STRATEGIES, I direct Medical Affairs, medical education, and MLR/PRC governance for organizations including UCB, J&J, BD, Novartis, and Pfizer. I’m developing a proprietary AI Regulatory Behavioral Intelligence Model to predict FDA approval pathways.
At UCB / ENGAGE THERAPEUTICS, I directed Medical Affairs strategy for Staccato Alprazolam and helped advance the acquisition of Engage Therapeutics. I also tripled epilepsy trial site selection efficiency and saved $2.5M through predictive modeling and clinical trial optimization.

